Evoke Wealth’s Repligen RGEN Stock Holding History

Evoke Wealth’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15	Closed	-$4K	–	1237
2021 Q4	$4K	Hold	15	–	–	﹤0.01%	956
2021 Q3	$4K	Hold	15	–	–	﹤0.01%	904
2021 Q2	$3K	Sell	15 -19	-56%	-$3.69K	﹤0.01%	1002
2021 Q1	$7K	Buy	+34	New	+$6.97K	﹤0.01%	773

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Evoke Wealth's RGEN Position: Q1 2022 in Review

Evoke Wealth sold out of Repligen (RGEN) in Q1 2022, closing a stake of 15 shares — an estimated $4K sold.

Evoke Wealth first reported a position in RGEN in Q1 2021 and held it in 4 quarters. The position peaked at $7K in Q1 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

Evoke Wealth reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
Evoke Wealth sold 15 Repligen shares in Q1 2022, an estimated $4K.
Evoke Wealth first reported a position in Repligen in Q1 2021 and held it in 4 quarters.
Evoke Wealth's Repligen position peaked at $7K in Q1 2021.
450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Evoke Wealth's 13F filing for Q1 2022, filed 10 May 2022.